Idaho Matters

Idaho Matters Doctors Roundtable: September 20, 2023

In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.

Broadcast on:: 20 Sep 2023

A generic of EpiPen, an epinephrine injection auto-injector, used for allergic reactions.(Tony Webster / Flickr)

In a surprise move yesterday the FDA put the brakes on a new drug that was supposed to take the place of EpiPen's to treat anaphylactic shock. And a nasty new virus is making the rounds in India.

Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to talk more.